Aptus Capital Advisors, LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1664193 FAIRHOPE, AL

Position in NBIX

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$223,315

-$15,661 QoQ

Shares Held

1,325

-27.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#585

of 768 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 98% Shared 0% None 2%

Healthcare · as of Jun 30, 2026

Aptus Capital Advisors, LLC holds $2,444,509 across 5 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (9.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	22,716	$1,632,371
2	HROW	Harrow, Inc.	5,301	$225,133
3	NBIX	Neurocrine Biosciences Inc This page	1,325	$223,315
4	HLN	Haleon plc	20,330	$189,678
5	VTRS	Viatris Inc	10,958	$174,012

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$223,315	1,325	-27.0%	Shares	Sole	2026-08-12
2026-03-31	$238,976	1,814	+8.8%	Shares	Sole	2026-05-11
2025-12-31	$236,430	1,667	—	Shares	Sole	2026-02-13
No filing history on record for this holder in this stock.